- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Immobilier
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Event 211 results
Webinar
mars 16, 2023
All About That Place: Personal Jurisdiction Over Nonresident Corporations Following Daimler
Webinar
mars 18, 2021
Let’s Talk Tech: What We Are Watching in 2021
Webinar
Webinar
mars 16, 2021
The New Intensified Scrutiny and Enforcement of FDA-Regulated Clinical Trials
Webinar
mars 4, 2021
Talk im Turm – AI & Life Sciences: Where do we stand in the EU and what to expect in 2021?
Webinar
février 25, 2021
International Arbitration of Technology Disputes: Perspectives from Silicon Valley and Singapore
Webinar
février 24, 2021
The Biden Administration’s U.S.-Asia Trade Priorities: What Businesses and Investors Need to Know
Webinar
février 23, 2021
FDA Inspections in 2021 for Drug and Device Manufacturers
Webinar
février 23, 2021
Key Food and Beverage Issues: Challenges and Opportunities in 2021
Webinar
février 16, 2021
Budget Reconciliation—A Conversation with Peter Robinson, Former Senate Senior Assistant Parliamentarian
Webinar
février 8, 2021
Egishe Dzhazoyan to Speak on American University of Armenia Virtual Panel